StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) stock

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1415.55−16.12 (-1.13%)

Close on Nov 17, 2026Market cap $1.33TP/E 45.9Yield 0.44%

Eli Lilly price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Eli Lilly's price to book ratio was 38.0× on Nov 11, 2026, against 40.7× a year earlier. Over the last 5 years it ranged from 25.4× to 65.5×, with a median of 38.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202638.0×−2.6
2025Dec 31, 202540.7×−8.3
2024Dec 31, 202449.0×+2.1
2023Dec 29, 202346.9×+14.0
2022Dec 30, 202232.9×+0.4
2021Dec 31, 202132.5×+0.6
2020Dec 31, 202031.9×−5.5
2019Dec 31, 201937.4×+28.2
2018Dec 31, 20189.2×+3.2
2017Dec 29, 20176.0×+1.0
2016Dec 30, 20165.0×−0.9
2015Dec 31, 20155.9×+1.7
2014Dec 31, 20144.2×+0.8
2012Apr 30, 20123.4×–

More Eli Lilly figures

See a number that looks wrong?